trial · primary record
NS-863 Low Dose
Pulmonary Arterial Hypertension
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 135 |
| Primary completion | 2028-11-01 |
| Primary endpoint | Change in pulmonary vascular resistance (PVR) at week 24 |
| Registry ID | NCT07441200 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:17.933Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07441200
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ns-863 Low Dose · compound